eXoZymes (EXOZ) Stock: Curia Deal Moves NCT Toward Commercial Production

TLDR EXOZ falls 4.86% to $6.50 after eXoZymes signs its Curia manufacturing deal. Curia will scale NCT work across facilities in León, Spain, and Rozzano, Italy. The Q4 2026 program will map a route toward larger-scale NCT production in 2027. Technology transfer covers enzyme fermentation, cell-free reaction and purification. eXoZymes aims to use Curia’s manufacturing [...]

The post eXoZymes (EXOZ) Stock: Curia Deal Moves NCT Toward Commercial Production appeared first on Blockonomi.